Komaki, Soichi
Ishii, Masanobu
Kaichi, Ryota
Takae, Masafumi
Mori, Takayuki
Toida, Reiko
Kurogi, Kazumasa
Matsuura, Yunosuke
Yamamoto, Nobuyasu
Tsujita, Kenichi
Tsuruda, Toshihiro
Kaikita, Koichi
Article History
Received: 25 September 2022
Accepted: 8 February 2023
First Online: 27 February 2023
Declarations
:
: Dr. Koichi Kaikita has received remuneration for lectures from Bayer Yakuhin Ltd., Daiichi-Sankyo Co. Ltd., Novartis Pharma AG., and Otsuka Pharmaceutical Co. Ltd.; has received trust research/joint research funds from Bayer Yakuhin Ltd. and Daiichi-Sankyo Co. Ltd.; and has received scholarship funds from Abbott Medical Co. Ltd. Dr. Kenichi Tsujita has received remuneration for lectures from Abbott Medical Co. Ltd., Amgen K.K., AstraZeneca K.K., Bayer Yakuhin Ltd., Daiichi-Sankyo Co. Ltd., Medtronic Japan Co. Ltd., Kowa Pharmaceutical Co. Ltd., Novartis Pharma K.K., Otsuka Pharmaceutical Co. Ltd., Pfizer Japan Inc., and Janssen Pharmaceutical K.K.; has received trust research/joint research funds from PPD-Shin Nippon Biomedical Laboratories K.K. and Alexion Pharmaceuticals Inc.; and has received scholarship funds from Abbott Medical Co. Ltd., Bayer Yakuhin Ltd., Boehringer Ingelheim Japan, Daiichi-Sankyo Co. Ltd., ITI Co. Ltd., ONO PHARMACEUTICAL CO. LTD., Otsuka Pharmaceutical Co. Ltd., and Takeda Pharmaceutical Co. Ltd.